Summary.-Immune complexes of 125I-HSA-rat anti-HSA formed in vivo under conditions of antibody excess were rapidly cleared from the circulation of both normal and leukaemic Hooded rats. In HSA-immune rats most of the 125I-HSA present in the blood was found to be cell-bound, but a proportion was present as circulating immune complexes that could be precipitated from plasma by 2.50/o polyethylene glycol. There was no evidence that clearance of a soluble antigen was impaired in leukaemic animals.
THE CLEARANCE of antigen from the circulation of an animal with specific antibody to that antigen (Dixon & Talmage, 1951 ) is dependent on a number of factors, perhaps the most important being the ratio of antigen to antibody in circulation (Weigle, 1958) . Most of the immune complexes formed in circulation that are of a size greater than 1 IS ( > Ag2Ab2) are rapidly cleared by the mononuclear phagocyte system. in particular by the Kupffer cells of the liver (Benacerraf et al., 1959; Arend & Mannik, 1971) . Smaller immune complexes, formed in antigen excess, have been found to remain longer in circulation, and some formed with low-mol.-wt antigens or haptens were found to circulate for considerable periods (Schmidt et al., 1974) .
The reticuloendothelial system can be saturated by large quantities of circulating soluble immune complexes (Haakenstad & Mannik, 1974) . Immune complexes containing tumour antigen have been found in the sera of tumour-bearing animals (Thomson et al., 1973) and the presence of such complexes has been adduced from the finding that tumour-bearer sera can abrogate lymphocyte cytotoxicity (Sjogren et al., 1971; Baldwin et al., 1972) . These observations have led to the concept that impairment of the immune clearance system in animals bearing tumours may be responsible for the continued presence of circulating immune complexes.
To investigate the immune clearance system in normal and tumour-bearing animals we have followed the disappearance from circulation of complexes formed in vivo between radiolabelled human serum albumin (HSA) and specific antibody. We have monitored the clearance of the immune complexes from circulation, both as the disappearance of labelled antigen and as the decrease in radioactivity that was precipitable from plasma by 2.5% polyethylene glycol. To each 0Iml sample of plasma-EDTA was added 10 ml of a solution containing 2.5% (w/v) polyethylene glycol 6000 (PEG, British Drug Houses Ltd, Poole, Dorset) and 0-075M NaCl in 0 li'i borate buffer (pH 8.3) (Zubler et al., 1976) . After 2 h at 0°C the tubes were centrifuged at 1500 g for 45 min in an MSE Mistral 6L centrifuge at 4TC. The supernatants were discarded and the radioactivity remaining in the tubes determined. The results were expressed as:
MATERIALS AND METHODS

Immunization
(1) Qo plasma 1251-HSA that was precipitable by PEG;
(2) 00 injected 1251 that was precipitalle by PEG. Tumour-bearing animals. The clearance of 125I-HSA from 4 normal and 4 immune rats was examined 10 days after these animals had been injected i.v. with 2 x 104 cells of the Hooded rat leukaemia (HRL; Wrathmell, 1976) . The passage number and cell concentration used caused death of the rats within 14 days, though they remained ostensibly well until 48 h before death. The experi-39 mental protocol was the same as that described for the non-tumour-bearing rats.
Labelling of human serum? albumin with 125Iodine HSA (AB Kabi, Stockholm, Sweden) was labelled with 125Jodine by the chloramine T mnethod (McConahey & Dixon, 1966) to sp.
act. 0 8-1 0 tCi/jug. Before use, the 1251-HSA wNas diluted 10-fold with unlabelled HSA to give a total input of 360 jg/rat.
Esti,mation of plasma levels of rat anti-HSA These were determined by passive haemagglutination, using HSA coupled to sheep red blood cells as the antigen source.
RESULTS
The clearance of 1251-HSA from the circulation of normal and immunized Hooded rats was followed for 6 h and the results are shown in the Figure. 89-3+2-5
11-4 + 4-6 84-7 + 4-8 10-1 + 3-4 73-6+ 3-1 10 0+ 2-9 75-6 + 7-3 93+2-9 61-9+2-1 8-0+2-7 56-2+7-9
In plasma decreased slowly and exponentially so that 6 h after injection about half the injected dose remained in circulation. During this time, virtually all the circulating 125I-HSA in the controls was present in the plasma fraction of the blood samples (Table I ). In the immune rats, where at 10 min 30% of the 1251-HSA remained in circulation, only 4.6% of the input was found in the plasma fraction, leaving 25.4% associated with the blood cells. These results show that soluble complexes of 1251-HSA-rat anti-HSA formed i.v. were rapidly taken up by the cellular components of the blood and cleared from circulation.
Samples of plasma were assayed at intervals for the presence of 1251-HSA-rat anti-HSA complexes that were precipitable by PEG at a final concentration of 2.5% (Tables I and III) . PEG-precipitable soluble immune complexes were cleared from circulation within 1 h though some PEG-precipitable material could be detected in the plasma of immune rats throughout the experiment (Table III) . To discover whether tumour-bearing animals retained their ability to clear soluble immune complexes from circulation, the experiment was repeated using HSA-immune and control rats that had been given 2 x 104 HRL cells i.v. 10 days before (see Methods). This Hooded rat leukaemia is a thy 1.1-bearing leukaemia (Wrathmell, 1976) without Fc receptors. The results presented in the Figure and Table II show that the clearance of 1251-HSA from the circulation in both immune and control tumour-bearing rats was not significantly different from that of nontumour-bearing animals. Again, 1251-HSA complexes could be detected in the plasma of tumour-bearing immune rats by precipitation with 2.5% PEG (Table III) . In one of the HSA-immune tumour-bearing animals, about 8% of the input of 1251-HSA was found to be precipitable by PEG from plasma taken at 10 min but in this animal no cell-bound radioactivity was detected then or subsequently. In the other tumour-bearing immune animals, however, more than 700o of the 1251-HSA in circullation at 10 min was cell-bound.
The haemagglutination titres of anti-LSA in all sera taken at the start of each experiment lay between 1/3200 to 1/6400 in the immune rats, whilst control rats wTere negative.
DISCUSSION
After a single i.v. infusion of 125I-HSA, the immune complexes formed in vivo by HSA-immune rats were cleared rapidly from circulation. We have shown that a proportion of these complexes were soluble and could be detected in vitro by precipitation from plasma with PEG. H-owever, the bulk of the radiolabelled antigen in the circulation of immune rats was bound to blood cells during the initial phase of immune clearance. In the control animals 125I-1HSA was cleared more slowly, all of the radioactivity being in the plasma fraction and none precipitable by PEG.
The reticuloendothelial system can be saturated by injecting immune complexes in slight antibody excess into normal mice (Haakenstad & Mannik, 1974 
